ArticleBMC cancer2019

Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia.

Oliver Herrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.